BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jesudian AB, de Jong YP, Jacobson IM. Emerging therapeutic targets for hepatitis C virus infection. Clin Gastroenterol Hepatol 2013;11:612-9.e1. [PMID: 23583900 DOI: 10.1016/j.cgh.2013.04.003] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Sussman NL, Remien CH, Kanwal F. The end of hepatitis C. Clin Gastroenterol Hepatol 2014;12:533-6. [PMID: 24480676 DOI: 10.1016/j.cgh.2014.01.025] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 3.0] [Reference Citation Analysis]
2 de Jong YP, Dorner M, Mommersteeg MC, Xiao JW, Balazs AB, Robbins JB, Winer BY, Gerges S, Vega K, Labitt RN. Broadly neutralizing antibodies abrogate established hepatitis C virus infection. Sci Transl Med. 2014;6:254ra129. [PMID: 25232181 DOI: 10.1126/scitranslmed.3009512] [Cited by in Crossref: 156] [Cited by in F6Publishing: 142] [Article Influence: 22.3] [Reference Citation Analysis]
3 Ball JK, Tarr AW, McKeating JA. The past, present and future of neutralizing antibodies for hepatitis C virus. Antiviral Res. 2014;105:100-111. [PMID: 24583033 DOI: 10.1016/j.antiviral.2014.02.013] [Cited by in Crossref: 91] [Cited by in F6Publishing: 86] [Article Influence: 11.4] [Reference Citation Analysis]
4 Margeridon-Thermet S, Le Pogam S, Li L, Liu TF, Shulman N, Shafer RW, Najera I. Similar prevalence of low-abundance drug-resistant variants in treatment-naive patients with genotype 1a and 1b hepatitis C virus infections as determined by ultradeep pyrosequencing. PLoS One. 2014;9:e105569. [PMID: 25140696 DOI: 10.1371/journal.pone.0105569] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
5 Patel AC. Clinical relevance of target identity and biology: implications for drug discovery and development. J Biomol Screen 2013;18:1164-85. [PMID: 24080260 DOI: 10.1177/1087057113505906] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
6 Shlomai A, de Jong YP, Rice CM. Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma. Semin Cancer Biol. 2014;26:78-88. [PMID: 24457013 DOI: 10.1016/j.semcancer.2014.01.004] [Cited by in Crossref: 91] [Cited by in F6Publishing: 88] [Article Influence: 11.4] [Reference Citation Analysis]
7 Richter C, Ter Beest G, Gisolf EH, VAN Bentum P, Waegemaekers C, Swanink C, Roovers E. Screening for chronic hepatitis B and C in migrants from Afghanistan, Iran, Iraq, the former Soviet Republics, and Vietnam in the Arnhem region, The Netherlands. Epidemiol Infect. 2014;142:2140-2146. [PMID: 24398373 DOI: 10.1017/s0950268813003415] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
8 Dunkelberg JC, Berkley EM, Thiel KW, Leslie KK. Hepatitis B and C in pregnancy: a review and recommendations for care. J Perinatol. 2014;34:882-891. [PMID: 25233195 DOI: 10.1038/jp.2014.167] [Cited by in Crossref: 58] [Cited by in F6Publishing: 46] [Article Influence: 7.3] [Reference Citation Analysis]
9 Kanwal F, El-Serag HB. Hepatitis C virus treatment: the unyielding chasm between efficacy and effectiveness. Clin Gastroenterol Hepatol 2014;12:1381-3. [PMID: 24607698 DOI: 10.1016/j.cgh.2014.02.031] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
10 von Schaewen M, Ploss A. Murine models of hepatitis C: what can we look forward to? Antiviral Res. 2014;104:15-22. [PMID: 24462693 DOI: 10.1016/j.antiviral.2014.01.007] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.1] [Reference Citation Analysis]
11 El-serag HB, Kramer J, Duan Z, Kanwal F. Epidemiology and outcomes of hepatitis C infection in elderly US Veterans. J Viral Hepat 2016;23:687-96. [DOI: 10.1111/jvh.12533] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 4.5] [Reference Citation Analysis]